ICD-10 Coding for Prolactinoma(C75.1, C75.1C, D35.2)
Comprehensive guide to ICD-10 coding for prolactinoma, including code relationships, documentation requirements, and clinical scenarios.
Complete code families applicable to Prolactinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D35.2 | Benign neoplasm of pituitary gland | Use when a benign tumor of the pituitary gland is confirmed by imaging. |
|
| E22.1 | Hyperprolactinemia | Use when elevated prolactin levels are documented and associated with a pituitary tumor. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutProlactinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Prolactinoma.
Not documenting tumor size
Impact
Clinical: Inadequate assessment of tumor impact., Regulatory: Non-compliance with documentation standards., Financial: Potential for incorrect DRG assignment.
Mitigation
Use templates prompting for tumor size., Educate staff on documentation standards.
Using E22.1 alone for pituitary mass
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Always pair E22.1 with D35.2 when a tumor is confirmed.
Incomplete documentation
Impact
Missing prolactin levels or imaging results.
Mitigation
Implement documentation checklists.